Mazumdar Shaw’s Mission to Expand Access to Vital Drugs
•Kiran Mazumdar-Shaw, known as India's 'Queen of Biotech,' founded Biocon nearly 50 years ago.
•Her company is a major global producer of insulin and a leader in biosimilars.
•Mazumdar-Shaw emphasizes the importance of expanding access to vital drugs and preparing India for an AI-driven future.
→Kiran Mazumdar-Shaw, known as India's 'Queen of Biotech,' founded Biocon nearly 50 years ago.
→Her company is a major global producer of insulin and a leader in biosimilars.
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Bloomberg. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Bloomberg. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.


